Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea
Clinical trial NCT06533865 · RECRUITING
Trial details
- NCT number
- NCT06533865
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-19
- Primary completion
- 2028-10-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.